How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN UROLOGICAL ASSOCIATION via AMERICAN UROLOGICAL ASSOCIATION
2026 · second_quarter · Q2
Reduce administrative burdens (e.g., prior authorization, step therapy, and medical malpractice) that negatively impact the practice of medicine and patient care; Advocate to ensure access to telehealth services as an alternative health care delivery model in urology to address access to care and health care equity; Enhance healthcare outcomes by ensuring equitable access to a full range of treatment options for all urologic conditions, regardless of patient demographics, geography, or financial status; Advocate for the full spectrum of prostate cancer care including, research, US Preventive Services Task Force (USPSTF) reforms, PSA screenings, and treatments for all patients; Address the needs of the urological workforce to protect against physician burnout for the continued longevity and expansion of the profession; Promote and protect funding for urologic research, including disparities in urologic care and patient access; Preserve the appropriate use of and payment for in-office ancillary services exception; Support policies to protect physician interests in the utilization of digital health technologies, including electronic health records and artificial intelligence, which impact the practice of urology; Encourage drug pricing and supply chain policies that ensure urologists ability to provide patient access to all pharmaceuticals or therapies; Advocate Congress for the creation of an Office of Men's Health in the Department of Health and Human Services.
Source: Senate LDA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN UROLOGICAL ASSOCIATION via AMERICAN UROLOGICAL ASSOCIATION
2026 · first_quarter · Q1
Reduce administrative burdens (e.g., prior authorization, step therapy, and medical malpractice) that negatively impact the practice of medicine and patient care; Advocate to ensure access to telehealth services as an alternative health care delivery model in urology to address access to care and health care equity; Enhance healthcare outcomes by ensuring equitable access to a full range of treatment options for all urologic conditions, regardless of patient demographics, geography, or financial status; Advocate for the full spectrum of prostate cancer care including, research, US Preventive Services Task Force (USPSTF) reforms, PSA screenings, and treatments for all patients; Address the needs of the urological workforce to protect against physician burnout for the continued longevity and expansion of the profession; Promote and protect funding for urologic research, including disparities in urologic care and patient access; Preserve the appropriate use of and payment for in-office ancillary services exception; Support policies to protect physician interests in the utilization of digital health technologies, including electronic health records and artificial intelligence, which impact the practice of urology; Encourage drug pricing and supply chain policies that ensure urologists ability to provide patient access to all pharmaceuticals or therapies; Advocate Congress for the creation of an Office of Men's Health in the Department of Health and Human Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE